They sold 33% of their Puma shares and 31% of their Genomic shares. Anybody hear any whispers about what's going on?
FMR, State Street and Renaissance sold a combined 1.2 million shares in Q2.
The only plus for me would be a combined change for the BlackRock entities of an additional 150,000 shares.
I'm not bothered about additions by Camber, North Tide and Tributary. When a hedge fund like Camber buys almost a million shares to double its holding to over 5% it isn't always a good thing.
Back to my question, which I'll rephrase .....
Has anybody here who isn't feeling gutted that he's spent the last nine months watching the value of his investment decrease by 24% heard anything?